← Leaderboards
Roberta Pelanda
University Of Colorado Denver
$15,844,961
Attributed
$17,233,945
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,233,945 · 13
By mechanism
R01$10,549,359 · 4
R21$2,590,566 · 6
T32$2,350,344 · 1
P01$1,380,914 · 1
R56$362,762 · 1
Top collaborators
- John C. Cambier7 shared
- Rosemary Rochford2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Philip Levon Simonian$2,505,595
- Taras Lyubchenko$1,011,250
- Matthew A Burchill$2,283,849
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularB-LymphocytesCellsAutoimmunityGenerationsAutoantigensAntibodiesAutoreactive B CellImmune SystemMouse ModelPathway InteractionsReceptorMediatingAutoantibodiesBaseAntigensImmunoglobulinsGenesPeripheralIn VivoPreventLeadAutoreactivityDefect
Grant awards (54)
Contribution and interplay of CXCR4 and integrins in central B cell tolerance$568,467
R01 · FY2025 · AI · contact PI
Contribution and interplay of CXCR4 and integrins in central B cell tolerance$568,467
R01 · FY2024 · AI · contact PI
Role and mechanisms of the PI3K pathway in B cell tolerance$420,383
R01 · FY2024 · AI · contact PI
Role and mechanisms of the PI3K pathway in B cell tolerance$420,383
R01 · FY2023 · AI · contact PI
Molecular Mechanisms of Immune Tolerance$394,085
T32 · FY2023 · AI · contact PI
Role and mechanisms of the PI3K pathway in B cell tolerance$420,383
R01 · FY2022 · AI · contact PI
Molecular Mechanisms of Immune Tolerance$388,265
T32 · FY2022 · AI · contact PI
Contribution of c-Maf to regulatory B cells and antibody-secreting cells$233,250
R21 · FY2022 · AI · contact PI
Role and mechanisms of the PI3K pathway in B cell tolerance$420,383
R01 · FY2021 · AI · contact PI
Molecular Mechanisms of Immune Tolerance$364,139
T32 · FY2021 · AI · contact PI
Contribution of c-Maf to regulatory B cells and antibody-secreting cells$194,375
R21 · FY2021 · AI · contact PI
Role and mechanisms of the PI3K pathway in B cell tolerance$420,383
R01 · FY2020 · AI · contact PI
Studies of human B cell tolerance, from a humanized mouse model to human beings$413,675
R01 · FY2020 · AI · contact PI
Molecular Mechanisms of Immune Tolerance$358,131
T32 · FY2020 · AI · contact PI
Studies of human B cell tolerance, from a humanized mouse model to human beings$678,093
R01 · FY2019 · AI · contact PI
Molecular Mechanisms of Immune Tolerance$338,755
T32 · FY2019 · AI · contact PI
Studies of human B cell tolerance, from a humanized mouse model to human beings$413,675
R01 · FY2018 · AI · contact PI
Molecular Mechanisms of Immune Tolerance$257,316
T32 · FY2018 · AI · contact PI
Testing an alternative model of central B cell tolerance$233,250
R21 · FY2018 · AI · contact PI
Tolerance in polyclonal and oligoclonal immune systems$459,662
R01 · FY2017 · AI · contact PI
Studies of human B cell tolerance, from a humanized mouse model to human beings$413,675
R01 · FY2017 · AI · contact PI
Molecular Mechanisms of Immune Tolerance$249,653
T32 · FY2017 · AI · contact PI
Developing a new model for EBV-mediated T cell diseases$233,250
R21 · FY2017 · AI · contact PI
Testing an alternative model of central B cell tolerance$194,375
R21 · FY2017 · AI · contact PI
Tolerance in polyclonal and oligoclonal immune systems$491,593
R01 · FY2016 · AI · contact PI
Studies of human B cell tolerance, from a humanized mouse model to human beings$427,550
R01 · FY2016 · AI · contact PI
Developing a new model for EBV-mediated T cell diseases$194,375
R21 · FY2016 · AI · contact PI
Tolerance in polyclonal and oligoclonal immune systems$25,388
R01 · FY2016 · AI · contact PI
Tolerance in polyclonal and oligoclonal immune systems$417,319
R01 · FY2015 · AI · contact PI
Tolerance in polyclonal and oligoclonal immune systems$424,671
R01 · FY2014 · AI · contact PI
Human B Cell Development and Function in Humanized Mice Expressing Human BAFF$119,320
R21 · FY2014 · AI · contact PI
Human B cell development and function in humanized mice expressing human BAFF$115,814
R21 · FY2014 · AI · contact PI
Tolerance in Polyclonal and Oligoclonal Immune Systems$409,031
R01 · FY2013 · AI · contact PI
Human B Cell Development and Function in Humanized Mice Expressing Human BAFF$198,125
R21 · FY2013 · AI · contact PI
Tolerance in Polyclonal and Oligoclonal Immune Systems$343,709
R01 · FY2012 · AI · contact PI
Tolerance in Polyclonal and Oligoclonal Immune Systems$343,718
R01 · FY2011 · AI · contact PI
Mechanisms of B Cell Survival and Death$278,612
P01 · FY2011 · AI · contact PI
Tolerance in Polyclonal and Oligoclonal Immune Systems$347,004
R01 · FY2010 · AI · contact PI
Mechanisms of B Cell Survival and Death$285,535
P01 · FY2010 · AI · contact PI
Tolerance in Polyclonal and Oligoclonal Immune Systems$350,148
R01 · FY2009 · AI · contact PI
Mechanisms of B Cell Survival and Death$276,961
P01 · FY2009 · AI · contact PI
Analysis of Human B Cell Tolerance in Humanized Mice$200,648
R21 · FY2009 · AI · contact PI
Mechanisms of B Cell Survival and Death$270,984
P01 · FY2008 · AI · contact PI
Analysis of Human B Cell Tolerance in Humanized Mice$250,283
R21 · FY2008 · AI · contact PI
Tolerance in Polyclonal and Oligoclonal Immune Systems$211,528
R01 · FY2008 · AI · contact PI
Tolerance in Polyclonal and Oligoclonal Immune Systems$362,762
R56 · FY2007 · AI · contact PI
Mechanisms of B Cell Survival and Death$268,822
P01 · FY2007 · AI · contact PI
Tolerance in polyclonal and oligoclonal immune systems$357,350
R01 · FY2006 · AI · contact PI
Modulatory signaling motifs in B cell antigen receptor function$228,501
R21 · FY2006 · AI · contact PI
Tolerance in polyclonal and oligoclonal immune systems$303,200
R01 · FY2005 · AI
Modulatory signaling motifs in B cell antigen receptor$195,000
R21 · FY2005 · AI
Tolerance in polyclonal and oligoclonal immune systems$24,637
R01 · FY2005 · AI
Tolerance in polyclonal and oligoclonal immune systems$303,200
R01 · FY2004 · AI
Tolerance in polyclonal and oligoclonal immune systems$151,684
R01 · FY2003 · AI